These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1679252)

  • 1. When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
    Christison GW; Kirch DG; Wyatt RJ
    Schizophr Bull; 1991; 17(2):217-45. PubMed ID: 1679252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacologic treatment of schizophrenia: a progress report.
    Donaldson SR; Gelenberg AJ; Baldessarini RJ
    Schizophr Bull; 1983; 9(4):504-27. PubMed ID: 6140750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational polypharmacy in schizophrenia.
    Wolkowitz OM
    Ann Clin Psychiatry; 1993 Jun; 5(2):79-90. PubMed ID: 8348207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benzodiazepines and schizophrenia, a review of the literature].
    Gaillard R; Ouanas A; Spadone C; Llorca PM; Lôo H; Baylé FJ
    Encephale; 2006; 32(6 Pt 1):1003-10. PubMed ID: 17372546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practical aspects of drug resistance in schizophrenia].
    Jarema M; Kucińska M
    Psychiatr Pol; 2000; 34(5):721-40. PubMed ID: 11202015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the neuroleptic-nonresponsive schizophrenic patient.
    Meltzer HY
    Schizophr Bull; 1992; 18(3):515-42. PubMed ID: 1357741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepines in the treatment of schizophrenia: an updated survey.
    Lingjaerde O
    Acta Psychiatr Scand; 1991 Nov; 84(5):453-9. PubMed ID: 1685616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy.
    Johns CA; Thompson JW
    Schizophr Bull; 1995; 21(4):607-19. PubMed ID: 8749888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenics fully remitted on neuroleptics for 3-5 years--to stop or continue drugs?
    Cheung HK
    Br J Psychiatry; 1981 Jun; 138():490-4. PubMed ID: 6117347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of treatment-resistant patients with schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation strategies in clozapine-resistant schizophrenia.
    Remington G; Saha A; Chong SA; Shammi C
    CNS Drugs; 2005; 19(10):843-72. PubMed ID: 16185094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia.
    Wolkowitz OM; Turetsky N; Reus VI; Hargreaves WA
    Psychopharmacol Bull; 1992; 28(3):291-5. PubMed ID: 1362277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.
    Wolkowitz OM; Pickar D; Doran AR; Breier A; Tarell J; Paul SM
    Am J Psychiatry; 1986 Jan; 143(1):85-7. PubMed ID: 2867690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug strategies and treatment-resistant schizophrenia.
    Pantelis C; Barnes TR
    Aust N Z J Psychiatry; 1996 Feb; 30(1):20-37. PubMed ID: 8724325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Treatment Strategies of Clozapine for Refractory Schizophrenia.
    Li YY; Zhang YS; Wang J; Li KQ; Wang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):666-678. PubMed ID: 28065233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychopharmacological treatment of treatment-resistant schizophrenia].
    Lublin HK
    Ugeskr Laeger; 1997 Nov; 159(48):7128-33. PubMed ID: 9417718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.